Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The opioid use disorder market was valued at USD 2.66 Billion in 2025. It is poised to grow at a CAGR of 10.00% during the forecast period of 2026-2035, and reach USD 6.90 Billion by 2035. The market growth is driven by rising opioid addiction cases, increasing awareness of treatment options, expanding medication-assisted therapies, supportive government initiatives, and advancements in long-acting treatment formulations globally.
Latest News on the Opioid Use Disorder Market (2026)
- In April 2026, Indivior presented ASAM data showing SUBLOCADE improved treatment retention and reduced overdose risk in opioid use disorder patients.
- In November 2025, Indivior reported AMCP Nexus real-world evidence showing monthly buprenorphine injections improved adherence and reduced healthcare utilization in opioid use disorder treatment.
- In February 2025, FDA approved SUBLOCADE label changes enabling rapid initiation after single dose and flexible injection sites for opioid use disorder therapy.
Key Market Trends and Insights
- Based on drug type, Buprenorphine segment is expected to dominate the market as it accounted for about 59% market share in the historical period.
- Based on route of administration, the oral segment is anticipated to lead the market.
- Based on region, North America is expected to dominate as it accounted for about 68% market share in the historical period.
Market Size and Forecast
- Market Size (2025): USD 2.66 Billion
- Projected Market Size (2035): USD 6.90 Billion
- CAGR (2026-2035): 10.00%
Compound Annual Growth Rate
10%
Value in USD Billion
2026-2035
Opioid Use Disorder Market Overview
The opioid use disorder market is expanding due to rising global opioid addiction cases, increasing awareness of treatment options, and growing adoption of medication-assisted therapies. Expansion of healthcare access programs and supportive government initiatives are further driving demand. Advancements in long-acting formulations, digital therapeutics, and integrated care approaches are improving treatment adherence and outcomes across patient populations globally. The market reached a value of approximately USD 2.66 Billion in 2025.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Opioid Use Disorder Market Growth Drivers
Increasing Regulatory Approvals and Product Innovation Accelerating the Market Expansion
Rising opioid dependence cases and increasing need for faster initiation of treatment are key factors driving innovation in medication-assisted therapies. These drivers are strengthening regulatory advancements in long-acting buprenorphine formulations. For instance, in February 2025, the FDA approved label changes for Indivior’s SUBLOCADE, enabling rapid initiation after a single dose and expanding injection sites to improve treatment flexibility. This development is expected to enhance adoption of medication-assisted treatment in the forecast period.
Opioid Use Disorder Market Trends
Key trends shaping the market include rising adoption of medication-assisted therapy, long-acting formulations, and integration of digital treatment solutions.
Long-Acting Buprenorphine Innovations Driving the Market Development
Growing need for improved adherence and reduced relapse rates in opioid use disorder is driving innovation in long-acting injectable therapies. These factors support the development of extended-release formulations globally. For instance, in November 2025, Indivior presented real-world evidence at AMCP Nexus 2025 showing that monthly SUBLOCADE injections improved treatment retention and reduced healthcare utilization among patients with opioid use disorder. This development is expected to strengthen adoption of long-acting injectable therapies in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Opioid Use Disorder Market Segmentation
Market Breakup by Drug Type
- Buprenorphine
- Methadone
- Naltrexone
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by Country
- United States
- United Kingdom
- Germany
- France
- Italy
- Spain
- Japan
- India
Opioid Use Disorder Market Share
Buprenorphine Segment Likely to Dominate the Market by Drug Type
The buprenorphine segment is expected to dominate the market as it accounted for about 59% revenue share in the historical period. Rising opioid dependence cases, increasing preference for medication-assisted treatment, and supportive regulatory frameworks are driving segment growth. Expanding use of opioid addiction treatment therapies is further enhancing patient outcomes and strengthening adoption across healthcare systems globally.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Opioid Use Disorder Market Analysis by Region
North America is expected to dominate as it accounted for about 68% share in the historical period. High prevalence of opioid misuse, strong healthcare infrastructure, and extensive treatment access programs are key growth drivers. Increasing adoption of medication-assisted treatment approaches further supports regional leadership and improves long-term recovery outcomes across healthcare settings.
Leading Players in the Opioid Use Disorder Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Indivior Pharmaceuticals, Inc.
Founded in 2014 and headquartered in Richmond, Virginia, USA, Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on addiction treatment therapies. Its portfolio includes SUBLOCADE and SUBOXONE for opioid use disorder management. The company plays a significant role in the opioid use disorder market through advancements in long-acting buprenorphine formulations, improving treatment adherence, relapse prevention, and long-term recovery outcomes.
Orexo US, Inc.
Headquartered in Morristown, New Jersey, USA, Orexo US, Inc. specializes in pharmaceutical treatments for opioid dependence and pain management. The company’s portfolio includes ZUBSOLV, a buprenorphine and naloxone sublingual tablet for opioid use disorder treatment. Orexo contributes to the opioid use disorder market by expanding access to medication-assisted treatment solutions and supporting improved patient compliance and recovery outcomes.
Titan Pharmaceuticals Inc.
Founded in 1992 and headquartered in South San Francisco, California, USA, Titan Pharmaceuticals Inc. develops long-term drug delivery technologies for chronic conditions. Its portfolio includes Probuphine, a subdermal implant delivering continuous buprenorphine therapy for opioid dependence. The company contributes to the opioid use disorder market through innovative implant-based treatment approaches that support sustained drug delivery and improved treatment adherence.
Viatris Inc.
Established in 2020 and headquartered in Canonsburg, Pennsylvania, USA, Viatris Inc. is a global healthcare company offering a broad portfolio of branded and generic pharmaceuticals. The company provides therapies used in addiction management and opioid dependence treatment. Viatris contributes to the opioid use disorder market by improving access to affordable treatment options and supporting the expansion of medication-assisted therapies globally.
Other key players in the market include Hikma Pharmaceuticals Plc, Braeburn Pharmaceuticals, Inc., Pear Therapeutics, Inc., Eli Lilly and Company, Alkermes Plc, and Camurus AB.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Key Questions Answered in the Opioid Use Disorder Market Report
- What was the opioid use disorder market value in 2025?
- What is the opioid use disorder market forecast outlook for 2026-2035?
- What major factors aid the demand for the opioid use disorder market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major opioid use disorder market trends?
- Which drug type are expected to dominate the market segment?
- Which route of administration are expected to dominate the market segment?
- Which distribution channel are expected to dominate the market segment?
- Who are the key players in the opioid use disorder market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Type |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
